Higher response to lenalidomide in relapsed/refractory diffuse large B‐cell lymphoma in nongerminal center B‐cell–like than in germinal center B‐cell–like phenotype FJ Hernandez‐Ilizaliturri, G Deeb, PL Zinzani, SA Pileri, F Malik, ... Cancer 117 (22), 5058-5066, 2011 | 383 | 2011 |
Immunomodulatory drugs stimulate natural killer‐cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti‐tumour activity of … N Reddy, FJ Hernandez‐Ilizaliturri, G Deeb, M Roth, M Vaughn, J Knight, ... British journal of haematology 140 (1), 36-45, 2008 | 313 | 2008 |
Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study D Tan, Q Li, G Deeb, N Ramnath, HK Slocum, J Brooks, R Cheney, ... Human pathology 34 (6), 597-604, 2003 | 210 | 2003 |
MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma SS Wenzel, M Grau, C Mavis, S Hailfinger, A Wolf, H Madle, G Deeb, ... Leukemia 27 (6), 1381-1390, 2013 | 127 | 2013 |
HER-2/neu Protein Expression and Gene Alteration in Stage I-IIIA Non–Small-Cell Lung Cancer: A Study of 140 Cases Using a Combination of High Throughput Tissue Microarray … D Tan, G Deeb, J Wang, HK Slocum, J Winston, S Wiseman, A Beck, ... Diagnostic Molecular Pathology 12 (4), 201-211, 2003 | 116 | 2003 |
Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and … G Deeb, J Wang, N Ramnath, HK Slocum, S Wiseman, A Beck, D Tan Modern Pathology 17 (4), 430-439, 2004 | 113 | 2004 |
Ofatumumab demonstrates activity against rituximab‐sensitive and‐resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B‐cell lymphoma MJ Barth, FJ Hernandez‐Ilizaliturri, C Mavis, PC Tsai, JF Gibbs, G Deeb, ... British journal of haematology 156 (4), 490-498, 2012 | 86 | 2012 |
Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia G Deeb, MM Vaughan, I McInnis, LA Ford, SNJ Sait, P Starostik, ... Leukemia research 35 (5), 579-584, 2011 | 84 | 2011 |
Plasma cell leukaemia and other aggressive plasma cell malignancies T Sher, KC Miller, G Deeb, K Lee, A Chanan‐Khan British journal of haematology 150 (4), 418-427, 2010 | 71 | 2010 |
Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and‐resistant lymphomas EA Brem, K Thudium, S Khubchandani, PC Tsai, SH Olejniczak, S Bhat, ... British journal of haematology 153 (5), 599-611, 2011 | 58 | 2011 |
Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report A Bharthuar, L Egloff, J Becker, M George, JW Lohr, G Deeb, RV Iyer Cancer chemotherapy and pharmacology 64, 177-181, 2009 | 54 | 2009 |
Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients R Kansal, G Deeb, M Barcos, M Wetzler, ML Brecher, AMW Block, ... American journal of clinical pathology 121 (4), 512-525, 2004 | 53 | 2004 |
Genomic profiling of myeloid sarcoma by array comparative genomic hybridization G Deeb, MR Baer, DP Gaile, SNJ Sait, M Barcos, M Wetzler, JM Conroy, ... Genes, Chromosomes and Cancer 44 (4), 373-383, 2005 | 39 | 2005 |
CD52 over-expression affects rituximab-associated complement-mediated cytotoxicity but not antibody-dependent cellular cytotoxicity: preclinical evidence that targeting CD52 … RI Cruz, FJ Hernandez-Ilizaliturri, S Olejniczak, G Deeb, J Knight, ... Leukemia & lymphoma 48 (12), 2424-2436, 2007 | 37 | 2007 |
Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray Y Collins, DF Tan, T Pejovic, G Mor, F Qian, T Rutherford, R Varma, ... International journal of molecular medicine 14 (1), 43-53, 2004 | 32 | 2004 |
Lipomatous hemangiopericytoma of the head and neck: immunohistochemical and DNA ploidy analyses SJ Alrawi, G Deeb, R Cheney, P Wallace, T Loree, N Rigual, W Hicks, ... Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2004 | 22 | 2004 |
CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populations J Francis, AV Dharmadhikari, SNJ Sait, G Deeb, PK Wallace, ... Leukemia & lymphoma 54 (7), 1517-1520, 2013 | 20 | 2013 |
Monoallelic and biallelic deletions of 13q14. 3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection MT Smonskey, AMW Block, G Deeb, AA Chanan-Khan, ZP Bernstein, ... American journal of clinical pathology 137 (4), 641-646, 2012 | 20 | 2012 |
Spontaneous remission in an older patient with relapsed FLT3 ITD mutant AML P Vachhani, JH Mendler, A Evans, G Deeb, P Starostik, PK Wallace, ... Case Reports in Hematology 2016, 2016 | 19 | 2016 |
Recurrent deletion of 9q34 in adult normal karyotype precursor B-cell acute lymphoblastic leukemia NJ Nowak, SNJ Sait, A Zeidan, G Deeb, D Gaile, S Liu, LA Ford, ... Cancer genetics and cytogenetics 199 (1), 15-20, 2010 | 18 | 2010 |